ClinicalTrials.Veeva

Menu

Hydration Dynamics and Influence of Beverage Composition

University of Illinois logo

University of Illinois

Status and phase

Completed
Phase 2
Phase 1

Conditions

Hydration
Dehydration
Fluid Retention

Treatments

Biological: Placebo
Biological: Oral Rehydration Solution 2
Biological: Oral Rehydration Solution 1

Study type

Interventional

Funder types

Other

Identifiers

NCT05111392
2021-0823
Abbott Nutrition (EAS) (Other Grant/Funding Number)

Details and patient eligibility

About

The study examines interactions between fluid availability in the gut and fluid retention in the body. The relative rate of fluid uptake, the expansion of the plasma volume, and percent of fluid retained by the body will be measured in response to ingestion of beverages of different composition. Healthy, euhydrated adults will be studied. The results will help establish formulations of beverages that sustain if not promote acute euhydration.

Full description

Using a randomized order for beverage treatments at three separate trials, subjects will ingest 1 Liter of one of three beverages in 10 minutes: water, a beverage with 2.5% glucose with 45 mmol sodium/L, or a beverage with 1.7% glucose with 60 mmol sodium/L. Before and repeatedly for 2 h after ingestion of the beverage, blood samples will be drawn for assessments of D2O, Hb, Hct, osmolality, sodium, and glucose. The rate of appearance of D2O will be evaluated using the area under the curve, the slope of the appearance, and half time to plateau. Comparisons will be made between beverages for indices of the rate of appearance of D2O, the change in PV over time, and cumulative urine excreted. The cumulative urine produced will be used to calculate a modified BHI for the two glucose-electrolyte beverages and water for comparison with 1.0 (expected for no beverage effect). We hypothesize faster absorption (D2O appearance rate), and better overall hydration (expanded PV and higher modified BHI) will occur for beverages containing glucose and sodium compared to water. Further, we hypothesize that of the electrolyte beverages, the beverage with higher sodium content will promote greater overall hydration (less urine excreted) than the beverage with lower sodium.

Enrollment

14 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Have a BMI of 18.5 to 29.9 kg/m2.
  • Be normotensive (<120/80 mm Hg).
  • Must be able to speak and read English.
  • Be physically active or a regular exerciser but be able to abstain from exercise for 48 h prior to each study trial.
  • Fast for at least 8 hours prior to and through the study trial.
  • Be able to abstain from alcohol for 48 h prior to each study.
  • Be able to abstain from caffeine for 24 h prior to each study.
  • If female, must have regular menstrual cycles, that are > 27 days and < 35 days in length.

Exclusion criteria

  • Under 18 y of age or over 45 y of age.
  • Have a BMI <18.5 or >30.
  • Being pregnant.
  • Lactating.
  • Tobacco user.
  • Have hypotension or hypertension.
  • Have any type of kidney disease or dysfunction.
  • Have diabetes.
  • Have any type of cardiovascular disease.
  • Have been diagnosed with galactosemia.
  • Females with irregular menstrual cycles.
  • Females with polycystic ovary disease.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

14 participants in 3 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Water
Treatment:
Biological: Placebo
Oral rehydration solution 1
Experimental group
Description:
Beverage with 2.5% glucose with 45 mmol sodium/L.
Treatment:
Biological: Oral Rehydration Solution 1
Oral rehydration solution 2
Experimental group
Description:
Beverage with 1.7% glucose with 60 mmol sodium/L.
Treatment:
Biological: Oral Rehydration Solution 2

Trial contacts and locations

1

Loading...

Central trial contact

Craig A Horswill, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems